The pharmaceutical industry is facing unprecedented disruption, necessitating a fundamental shift in how leaders perceive and respond to market dynamics. Traditional commercial models are no longer ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. The pharmaceutical industry is in the midst of profound ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

Meta Platforms Inc. is planning to release a commercial version of its artificial intelligence model designed for commercial use, according to a report today from the Financial Times. Meta released ...

In my previous column, I discussed how pharmaceutical and medical device companies are adapting their commercial model approaches in critical areas to address growing economic, market and other ...